Photo from wikipedia
There is an unmet need for a reliable biomarker for the differentiation of axial spondyloarthritis (AxSpA) from its mimickers. Serum levels of interleukin‐22 (IL‐22) have previously been found to be… Click to show full abstract
There is an unmet need for a reliable biomarker for the differentiation of axial spondyloarthritis (AxSpA) from its mimickers. Serum levels of interleukin‐22 (IL‐22) have previously been found to be significantly elevated in patients with AxSpA compared with healthy individuals or persons with osteoarthritis.
Keywords:
association elevated;
axial spondyloarthritis;
interleukin clinical;
elevated serum;
spondyloarthritis;
serum interleukin
Journal Title: International Journal of Rheumatic Diseases
Year Published: 2021
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!
Journal Title: International Journal of Rheumatic Diseases
Year Published: 2021
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!